TNFRSF8 and neoplasm: Brentuximab vedotin (SGN-35) is an immunotoxin composed of a CD30 directed antibody linked to the antitubulin agent monomethyl auristatin E (MMAE).17,28 The antibody drug conjugate enables the antibody to selectively deliver a chemotherapy agent to CD30 positive tumor cells.